These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 21292815
1. Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease. Heffernan KS, Kuvin JT, Sarnak MJ, Perrone RD, Miskulin DC, Rudym D, Chandra P, Karas RH, Menon V. Nephrol Dial Transplant; 2011 Aug; 26(8):2515-21. PubMed ID: 21292815 [Abstract] [Full Text] [Related]
2. Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease. Menon V, Rudym D, Chandra P, Miskulin D, Perrone R, Sarnak M. Clin J Am Soc Nephrol; 2011 Jan; 6(1):7-13. PubMed ID: 20829421 [Abstract] [Full Text] [Related]
10. The association of endothelin-1 levels with renal survival in polycystic kidney disease patients. Kocyigit I, Eroglu E, Kaynar AS, Kocer D, Kargi S, Zararsiz G, Bayramov R, Imamoglu H, Sipahioglu MH, Tokgoz B, Dundar M, Oymak O. J Nephrol; 2019 Feb; 32(1):83-91. PubMed ID: 30022320 [Abstract] [Full Text] [Related]
11. Association of OSR-1 With Vascular Dysfunction and Hypertension in Polycystic Kidney Disease. Kocyigit I, Taheri S, Eroglu E, Zararsiz G, Sener EF, Uzun I, Imamoglu H, Mehmetbeyoglu E, Unal A, Korkmaz K, Sipahioglu MH, Oymak O, Tokgoz B. Ther Apher Dial; 2020 Feb; 24(1):64-71. PubMed ID: 31020807 [Abstract] [Full Text] [Related]
12. Endothelial dysfunction and oxidative stress in polycystic kidney disease. Klawitter J, Reed-Gitomer BY, McFann K, Pennington A, Klawitter J, Abebe KZ, Klepacki J, Cadnapaphornchai MA, Brosnahan G, Chonchol M, Christians U, Schrier RW. Am J Physiol Renal Physiol; 2014 Dec 01; 307(11):F1198-206. PubMed ID: 25234311 [Abstract] [Full Text] [Related]
13. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease. Park HC, Kim J, Cho A, Kim DH, Lee YK, Ryu H, Kim H, Oh KH, Oh YK, Hwang YH, Lee KB, Kim SW, Kim YH, Lee J, Ahn C, KNOW-CKD Investigators Group. J Korean Med Sci; 2020 Jun 08; 35(22):e165. PubMed ID: 32508065 [Abstract] [Full Text] [Related]
14. Alterations of Proximal Tubular Secretion in Autosomal Dominant Polycystic Kidney Disease. Wang K, Zelnick LR, Chen Y, Hoofnagle AN, Watnick T, Seliger S, Kestenbaum B. Clin J Am Soc Nephrol; 2020 Jan 07; 15(1):80-88. PubMed ID: 31628117 [Abstract] [Full Text] [Related]
16. Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease. Nowak KL, Cadnapaphornchai MA, Chonchol MB, Schrier RW, Gitomer B. Am J Nephrol; 2016 Jan 07; 44(3):171-8. PubMed ID: 27548646 [Abstract] [Full Text] [Related]
17. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease. Coban M, Inci A. Int Urol Nephrol; 2018 Jul 07; 50(7):1293-1300. PubMed ID: 29654395 [Abstract] [Full Text] [Related]
20. Nutritional Status is Associated With Preserved Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease. Lee J, Ryu H, Kim YC, Park HC, Ahn C, Lee KB, Kim YH, Kim Y, Han S, Bae EH, Oh KH, Oh YK. J Ren Nutr; 2023 Jul 07; 33(4):529-537. PubMed ID: 36965751 [Abstract] [Full Text] [Related] Page: [Next] [New Search]